Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Journal of Virology
|
April 13, 2012
Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein
Christopher T Lemke, Steve Titolo, Uta von Schwedler, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2013
Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: in vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
Claudio F Sturino, Yves Bousquet, Clint A James, et al.
Journal of Medical Internet Research
|
October 30, 2020
A Web Application About Herd Immunity Using Personalized Avatars: Development Study
Hina Hakim, Julie A Bettinger, Christine T Chambers, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 27, 2013
The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway
Sherri Smith, Jennifer Hoyt, Nigel Whitebread, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2013
Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors
Martin Tremblay, Richard C Bethell, Michael G Cordingley, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Journal of Virology
|
April 13, 2012
Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein
Christopher T Lemke, Steve Titolo, Uta von Schwedler, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 16, 2013
Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: in vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors
Claudio F Sturino, Yves Bousquet, Clint A James, et al.
Journal of Medical Internet Research
|
October 30, 2020
A Web Application About Herd Immunity Using Personalized Avatars: Development Study
Hina Hakim, Julie A Bettinger, Christine T Chambers, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
March 27, 2013
The pre-clinical absorption, distribution, metabolism and excretion properties of IPI-926, an orally bioavailable antagonist of the hedgehog signal transduction pathway
Sherri Smith, Jennifer Hoyt, Nigel Whitebread, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 21, 2013
Identification of benzofurano[3,2-d]pyrimidin-2-ones, a new series of HIV-1 nucleotide-competing reverse transcriptase inhibitors
Martin Tremblay, Richard C Bethell, Michael G Cordingley, et al.
Page
of 3